Myriad Announces GeneSight® Psychotropic Results from a Large Prospective Trial in Patients with Major Depressive Disorder

GeneSight Demonstrated Statistically Significant Improvement in the Gold Standard Clinical Outcomes of Remission and Response SALT LAKE CITY, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Assurex Health, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), today announced positive results from a double-blind, multi-center, randomized controlled trial assessing the impact of the GeneSight® Psychotropic test (GeneSight) on [...]

GeneSight® Shown to Statistically Significantly Improve Generalized Anxiety Disorder Treatment Response and Decrease Benzodiazepine Use

Positive Results Presented at the 25th World Congress of Psychiatric Genetics Salt Lake City, Oct. 19, 2017 – Assurex Health, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), today announced new positive results for the GeneSight® test in patients with Generalized Anxiety Disorder (GAD). The study found that GeneSight guided treatment statistically significantly improved treatment [...]

Virginia C. Drosos, President of Assurex Health, Receives the EY Entrepreneur of the Year 2017 Award in Ohio Valley Region

SALT LAKE CITY, June 19, 2017 – Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, today announced that Virginia ("Gina") C. Drosos, president of Assurex Health, a wholly-owned subsidiary of Myriad Genetics, has received the EY Entrepreneur of the Year award for health care services in the Ohio Valley Region. [...]

GeneSight® Psychotropic Test Demonstrated Substantial Cost Savings for Payers in New Study Published in Clinical Therapeutics

Economic Utility Study Showed Annual Cost Savings of $3,988 per Member SALT LAKE CITY, Feb. 23, 2017 (GLOBE NEWSWIRE) -- Assurex Health, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), today announced that new data on the use of the GeneSight® Psychotropic test to deliver medication cost savings for mental health disorders was published in [...]

Back to School is Appropriate Time to Evaluate ADHD Medication Choice

Parents often stop children’s ADHD meds at summer break. Now, a genetic test could help ensure they get back on the right ones. MASON, Ohio – August 23, 2016 – During summer months, many parents give their kids a break from the challenges of managing an ADHD medication regimen.  In fact, a review of [...]

Assurex Health to be Acquired by Myriad Genetics

Leader in Precision Medicine for Mental Health Treatment Decisions Sees Significant Strategic Benefits; Will Keep Headquarters in Mason, Ohio MASON, Ohio, August 3, 2016 –  Assurex Health, the world leader in genetic testing to guide behavioral health medication decisions, today announced it will become a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ: MYGN), [...]

Assurex Health Announces Key Leadership Hires To Support Continued Growth

Eckert, Findley to Guide Legal, People Teams; Verratti to Focus on GeneSight® Adoption Mason, Ohio – March 15, 2016 – Assurex Health, Inc., an informatics-based precision medicine company known primarily for its GeneSight test, a clinically proven test to help enhance medication selection for neuropsychiatric conditions, has announced appointments to three key leadership roles. Inger [...]

Assurex Health Passes Quarter Million Patients Tested with GeneSight

Company Announces Milestone on National Patient Recognition Day   Mason, Ohio – February 3, 2016 – Assurex Health, Inc. marked National Patient Recognition Day today by thanking the 250,000 patients who have taken an important step toward mental wellness through GeneSight® testing and the 15,000 healthcare providers who have used the test to help guide [...]

National Network of Depression Centers and Assurex Health Team up to Tackle Depression

Advertorial, Social Media Campaign to Raise Awareness About the Stigma of Depression and Mental Illness Ann Arbor, MI and Mason, OH – January 28, 2016 – The National Network of Depression Centers (NNDC), along with partner Assurex Health today announced the launch of #tackledepression, a national social media campaign to raise awareness that depression is [...]

Assurex Health Secures $15 Million in New Financing With a Series D Extension

Continues Growth in Industry-Leading Clinical Adoption, Research, and Technology MASON, OH – December 21, 2015 – Assurex Health, Inc., a commercial-stage, informatics-based precision medicine company providing treatment decision support to healthcare providers for behavioral health and chronic pain conditions, has secured an additional $15 million in equity financing from existing Series D investors, according to [...]